U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07207876) titled 'Study of Ceftriaxone and Benzathine Penicillin G During Pregnancy' on Sept. 19.
Brief Summary: IMPAACT 2044 is a study to characterize the pharmacokinetics (PK) and safety of ceftriaxone and benzathine penicillin G during pregnancy. Up to 78 pregnant women receiving (1) ceftriaxone for indications other than syphilis or (2) benzathine penicillin G for treatment of syphilis from non-study clinical care providers will be enrolled at study sites located in the United States. Approximately 22 infants of pregnant participants receiving benzathine penicillin G will also be enrolled.
Study Start Date: Nov. 30
Study Type: OBSERVATIONAL
Co...